This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrión, A. M.
Right arrow Articles by Naranjo, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrión, A. M.
Right arrow Articles by Naranjo, J. R.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 1998, p. 6921-6929, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Protein Kinase A-Dependent Derepression of the Human Prodynorphin Gene via Differential Binding to an Intragenic Silencer Element

Angel M. Carrión, Britt Mellström, and Jose R. Naranjo*

Instituto de Neurobiología, Consejo Superior de Investigaciones Científicas, 28002 Madrid, Spain

Received 5 June 1998/Returned for modification 30 July 1998/Accepted 19 August 1998

Induction of the prodynorphin gene has been implicated in medium and long-term adaptation during memory acquisition and pain. By 5' deletion mapping and site-directed mutagenesis of the human prodynorphin promoter, we demonstrate that both basal transcription and protein kinase A (PKA)-induced transcription in NB69 and SK-N-MC human neuroblastoma cells are regulated by the GAGTCAAGG sequence centered at position +40 in the 5' untranslated region of the gene (named the DRE, for downstream regulatory element). The DRE repressed basal transcription in an orientation-independent and cell-specific manner when placed downstream from the heterologous thymidine kinase promoter. Southwestern blotting and UV cross-linking experiments with nuclear extracts from human neuroblastoma cells or human brain revealed a protein complex of approximately 110 kDa that specifically bound to the DRE. Forskolin treatment reduced binding to the DRE, and the time course paralleled that for an increase in prodynorphin gene expression. Our results suggest that under basal conditions, expression of the prodynorphin gene is repressed by occupancy of the DRE site. Upon PKA stimulation, binding to the DRE is reduced and transcription increases. We propose a model for human prodynorphin activation through PKA-dependent derepression at the DRE site.


* Corresponding author. Mailing address: Instituto de Neurobiología, C.S.I.C., Av. Dr. Arce 37, 28002 Madrid, Spain. Phone: 34 1 585 4726. Fax: 34 1 585 4754. E-mail: JRNARANJO{at}SAMBA.CNB.UAM.ES.


Molecular and Cellular Biology, December 1998, p. 6921-6929, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Rivas, M., Mellstrom, B., Torres, B., Cali, G., Ferrara, A. M., Terracciano, D., Zannini, M., Morreale de Escobar, G., Naranjo, J. R. (2009). The DREAM Protein Is Associated with Thyroid Enlargement and Nodular Development. Mol. Endocrinol. 23: 862-870 [Abstract] [Full Text]  
  • Mellstrom, B., Savignac, M., Gomez-Villafuertes, R., Naranjo, J. R. (2008). Ca2+-Operated Transcriptional Networks: Molecular Mechanisms and In Vivo Models. Physiol. Rev. 88: 421-449 [Abstract] [Full Text]  
  • Matsuda, M., Yamamoto, T.-a., Hirata, M. (2006). Ca2+-Dependent Regulation of Calcitonin Gene Expression by the Transcriptional Repressor DREAM. Endocrinology 147: 4608-4617 [Abstract] [Full Text]  
  • Jacobson, D. A., Cho, J., Landa, L. R. Jr., Tamarina, N. A., Roe, M. W., Buxbaum, J. D., Philipson, L. H. (2006). Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression. Am. J. Physiol. Endocrinol. Metab. 291: E587-E595 [Abstract] [Full Text]  
  • Zamorano, R., Suchindran, S., Gainer, J. V. (2006). 3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression. Am. J. Physiol. Renal Physiol. 290: F456-F464 [Abstract] [Full Text]  
  • Gomez-Villafuertes, R., Torres, B., Barrio, J., Savignac, M., Gabellini, N., Rizzato, F., Pintado, B., Gutierrez-Adan, A., Mellstrom, B., Carafoli, E., Naranjo, J. R. (2005). Downstream Regulatory Element Antagonist Modulator Regulates Ca2+ Homeostasis and Viability in Cerebellar Neurons. J. Neurosci. 25: 10822-10830 [Abstract] [Full Text]  
  • Osawa, M., Dace, A., Tong, K. I., Valiveti, A., Ikura, M., Ames, J. B. (2005). Mg2+ and Ca2+ Differentially Regulate DNA Binding and Dimerization of DREAM. J. Biol. Chem. 280: 18008-18014 [Abstract] [Full Text]  
  • Scsucova, S., Palacios, D., Savignac, M., Mellstrom, B., Naranjo, J. R., Aranda, A. (2005). The repressor DREAM acts as a transcriptional activator on Vitamin D and retinoic acid response elements. Nucleic Acids Res 33: 2269-2279 [Abstract] [Full Text]  
  • Rivas, M., Mellstrom, B., Naranjo, J. R., Santisteban, P. (2004). Transcriptional Repressor DREAM Interacts with Thyroid Transcription Factor-1 and Regulates Thyroglobulin Gene Expression. J. Biol. Chem. 279: 33114-33122 [Abstract] [Full Text]  
  • Link, W. A., Ledo, F., Torres, B., Palczewska, M., Madsen, T. M., Savignac, M., Albar, J. P., Mellstrom, B., Naranjo, J. R. (2004). Day-Night Changes in Downstream Regulatory Element Antagonist Modulator/Potassium Channel Interacting Protein Activity Contribute to Circadian Gene Expression in Pineal Gland. J. Neurosci. 24: 5346-5355 [Abstract] [Full Text]  
  • de los Santos-Arteaga, M., Sierra-Dominguez, S. A., Fontanella, G. H., Delgado-Garcia, J. M., Carrion, A. M. (2003). Analgesia Induced by Dietary Restriction Is Mediated by the {kappa}-Opioid System. J. Neurosci. 23: 11120-11126 [Abstract] [Full Text]  
  • Sakai, N., Thome, J., Newton, S. S., Chen, J., Kelz, M. B., Steffen, C., Nestler, E. J., Duman, R. S. (2002). Inducible and Brain Region-Specific CREB Transgenic Mice. Mol. Pharmacol. 61: 1453-1464 [Abstract] [Full Text]  
  • Carafoli, E. (2002). Calcium signaling: A tale for all seasons. Proc. Natl. Acad. Sci. USA 99: 1115-1122 [Abstract] [Full Text]  
  • Ledo, F., Carrión, A. M., Link, W. A., Mellström, B., Naranjo, J. R. (2000). DREAM-alpha CREM Interaction via Leucine-Charged Domains Derepresses Downstream Regulatory Element-Dependent Transcription. Mol. Cell. Biol. 20: 9120-9126 [Abstract] [Full Text]  
  • SUSINI, S., VAN HAASTEREN, G., LI, S., PRENTKI, M., SCHLEGEL, W. (2000). Essentiality of intron control in the induction of c-fos by glucose and glucoincretin peptides in INS-1 {beta}-cells. FASEB J. 14: 128-136 [Abstract] [Full Text]  
  • Osawa, M., Tong, K. I., Lilliehook, C., Wasco, W., Buxbaum, J. D., Cheng, H.-Y. M., Penninger, J. M., Ikura, M., Ames, J. B. (2001). Calcium-regulated DNA Binding and Oligomerization of the Neuronal Calcium-sensing Protein, Calsenilin/DREAM/KChIP3. J. Biol. Chem. 276: 41005-41013 [Abstract] [Full Text]